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Background: To stratify non-ischemic cardiomyopathy subjects for risk using a combination of the number of morphological types of ventricular 
premature beats (VPB) on 12-lead Holter ECG and the presence of fibrosis in left ventricle (LV) on 320 slice CT.
Methods: 64 consecutive patients (46 males, 61 ± 14 yrs) who satisfied definitions of cardiomyopathies in Circulation 2006 underwent CT and 
12-lead Holter ECG within 12 months. Subjects had no significant coronary stenosis (≥50%) on CT (48 HCM, 5 DCM, and 1 ARVC) and were followed 
for a median of 50 months.
result: Fibrosis was detected in 41 patients. MACE occurred in 9 subjects. Kaplan Meier analysis revealed significant difference in incidence 
of MACE between non-ischemic cardiomyopathy subjects ± LV fibrosis (P = 0.009). According to a ROC curve, the best cutoff value to distinguish 
subjects ± MACE was 12 morphological types of VPB (sensitivity 66.7%, specificity 92.7% and AUC 0.783). We then divided subjects into 3 groups; 
Group 1: presence of fibrosis and number of morphological types of VPBs ≥ 12, Group 2: presence of fibrosis with number of morphological types of 
VPBs < 12 and Group 3: absence of LV fibrosis. Kaplan Meier analysis revealed a significant difference in incidence of MACE between Group 1 and 3 
and Group 1 and 2 (both P < 0.001).
conclusion: The presence of fibrosis on CT may predict poor prognosis in non-ischemic cardiomyopathy subjects. Furthermore, using number of 
morphological types of VPB, we successfully stratified these subjects for risk of MACE.
 
